CCRCB Seminar Programme 2009-2010

Date: Thursday, 10 June 2010

Seminar Speaker: Professor David Fernig,

Professor of Biological Chemistry, School of Biological Sciences, University of Liverpool, Liverpool, UK

Title of Lecture: “Getting to grips with the cellular microenvironment in health and disease”

 

Date: Thursday, 3 June 2010

Seminar Speaker: Professor Adrian Harris,

Cancer Research UK Professor of Medical Oncology, Weatherall Institute of Molecular Medicine, University of Oxford, UK

Title of Lecture: “Mechanisms of response and resistance to anti-angiogenesis therapy”

 

Date: Friday, 28 May 2010

Seminar Speaker: Professor Michael Olson,

Beatson Institute for Cancer Research, Glasgow, Scotland

Title of Lecture: “ROCK and LIMK signalling in tumour growth and invasion”

 

Date: Thursday, 13 May 2010

Seminar Speaker: Dr Ultan McDermott,

CDF Group Leader and CRUK Clinician Scientist Cancer Genome Project,

Wellcome Trust Sanger Institute, Cambridge, UK

Title of Lecture: “Integrating genomic datasets and drug sensitivity in cancer: A model

for biomarker discovery”

 

Date: Thursday, 6 May 2010

Seminar Speaker: Dr Kevin Ryan,

Beatson Institute for Cancer Research, Glasgow, Scotland

Title of Lecture: “Apoptosis and Autophagy in cell death and cancer”

 

Date: Thursday, 29 April 2010

Seminar Speaker: Dr Michael Way,

Cell Motility Laboratory, Cancer Research UK, London Research Institute

Title of Lecture: “Using Vaccinia virus to understand signalling dynamics and regulation

of actin polymerization”

 

Date: Thursday, 15 April 2010

Seminar Speaker: Dr Lorenzo Manti,

Radiation Biophysics Laboratory, Department of Physical Sciences, University of Naples, Italy

Title of Lecture: “Stress-induced Premature Cellular Senescence: implications for

radiotherapy”

 

Date: Thursday, 25 March 2010

Seminar Speaker: Dr Doug Winton,

Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Cambridge

Title of Lecture: “Functional approaches to interrogating intestinal stem cells”

 

Date: Thursday, 25 February 2010

Seminar Speaker: Professor Nick La Thangue,

Chair of Cancer Biology, Laboratory of Cancer Biology, University of Oxford, UK

Title of Lecture: “The Cancer Cell Cycle and Drug Discovery”

 

Date: Thursday, 11 February 2010

Seminar Speaker: Dr Sharon Tooze,

Secretory Pathways Laboratory, Cancer Research UK, London Research Institute

Title of Lecture: “Trafficking and signalling in mammalian autophagy”

 

Date: Thursday, 28 January 2010

Seminar Speaker: Professor Alan Rickinson,

School of Cancer Sciences, College of Medical and Dental Sciences,

University of Birmingham, UK

Title of Lecture: “Living with Epstein-Barr Virus: where virology, immunology and oncology meet”

 

Date: Thursday, 14 January 2010

Seminar Speaker: Dr Chris Pepper,

Department of Haematology, School of Medicine, Cardiff University, Wales

Title of Lecture: “The biological significance of CD38 in CLL - new insights following lentiviral transduction”

 

Date: Thursday, 17 December 2009

Seminar Speaker: Dr Seamas Donnelly,

College of Life Sciences, St. Vincent's University Hospital, University College Dublin, Ireland

Title of Lecture: “Macrophage Migration Inhibitory factor (MIF), inflammation and

cancer”

 

Date: Thursday, 10 December 2009

Seminar Speaker: Professor John Kelly,

Division of Surgery and Interventional Science, UCL Medical School,

University College London

Title of Lecture: “Translational science and surgery”

 

Date: Friday, 4 December 2009

Seminar Speaker: Professor Chris Proud,

School of Biological Sciences, University of Southampton, UK

Title of Lecture: “mTOR: a ‘master regulator’ of cell function”

 

Date: Thursday, 19 November 2009

Seminar Speaker: Professor Paul Clarke,

Biomedical Research Institute, University of Dundee, Scotland, UK

Title of Lecture: “Control of apoptosis during mitosis”

 

Date: Friday, 13 November 2009

Seminar Speaker: Professor Charles Craddock,

Centre for Clinical Haematology University of Birmingham, Queen Elizabeth Medical Centre, UK

Title of Lecture: “New Drug and Transplant Therapies in AML”

 

Date: Thursday, 5 November 2009

Seminar Speaker: Dr Derek Brazil,

Centre for Vision and Vascular Science, Queen’s University Belfast

Title of Lecture: “Insulin signalling in development and disease”

 

Date: Monday, 2 November 2009

Seminar Speaker: Dr Olivier Micheau,

INSERM U866: University of Burgundy, Dijon, France

Title of Lecture: “Drug-induced sensitization to Apo2L/TRAIL primarily involves

enhanced DISC formation and caspase-8 activation”

 

Date: Monday, 2 November 2009

Seminar Speaker: Dr Andy Takle,

Director of Translational Research, Cancer Research UK, London, UK

Title of Lecture: “Potent and selective inhibitors of B-Raf Kinase”

 

Date: Thursday, 29 October 2009

Seminar Speaker: Professor Neil Perkins,

Department of Cellular and Molecular Medicine, School of Medical Sciences, University of

Bristol, UK

Title of Lecture: “Regulation of cancer cell proliferation and survival by NF-KB”

 

Date: Thursday, 22 October 2009

Seminar Speaker: Professor Richard Marais,

Professor of Molecular Oncology, Institute for Cancer Research, Chester Beattie Laboratories, London, UK

Title of Lecture: “B-RAF signalling in cancer: biology and therapeutics”

 

Date: Thursday, 8 October 2009

Seminar Speaker: Dr Brian Huntly,

Cambridge Institute for Medical Research, Cambridge, UK

Title of Lecture: “A myeloid medley: differentiation specific effects of oncogenes in

AML and MPN”